1
|
Fahmi A, Abdur-Rahman M, Mahareek O, shemis MA. Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system. BMC Chem 2022; 16:95. [DOI: 10.1186/s13065-022-00888-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Accepted: 10/29/2022] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Free doxorubicin (Dox) is used as a chemotherapeutic agent against hepatocellular carcinoma (HCC), but it results in cardiotoxicty as a major side effect. Hence, a controlled Dox drug delivery system is extremely demanded.
Methods
Dox was loaded into the non-toxic biodegradable polycaprolactone (PCL) nanocapsules using the double emulsion method. Characterization of Dox-PCL nanocapsules was done using transmission electron microscopy and dynamic light scattering. Encapsulation efficiency and drug loading capacity were quantified using UV–visible spectrophotometry. Drug release was investigated in vitro at both normal (7.4) and cancer (4.8) pHs. Cytotoxicity of Dox-PCL nanocapsules against free Dox was evaluated using the MTT test on normal (Vero) and hepatic cancer (HepG2) cell lines.
Results
Spherical nanocapsules (212 ± 2 nm) were succeffully prepared with a zeta potential of (-22.3 ± 2 mv) and a polydisperse index of (0.019 ± 0.01) with a narrow size distribution pattern. The encapsulation efficiency was (73.15 ± 4%) with a drug loading capacity of (16.88 ± 2%). Importantlly, Dox-release from nanocapsules was faster at cancer pH (98%) than at physiological pH (26%). Moreover, although Dox-PCL nanocapsules were less toxic on the normal cell line (GI 50 = 17.99 ± 8.62 µg/ml) than free Dox (GI 50 = 16.53 ± 1.06 µg/ml), the encapsulated Dox showed higher toxic effect on cancer HepG2 cells compared to that caused by the free drug (GI 50 = 2.46 ± 0.49 and 4.22 ± 0.04 µg/ml, respectively).
Conclusion
The constructed Dox-PCL nanocapsules constitute a potentially controlled anti-HCC therapy with minimal systemic exposure.
Graphical Abstract
Collapse
|
2
|
Aminoleslami D, Porrang S, Vahedi P, Davaran S, Selakovic D. Synthesis and Characterization of a Novel Dual-Responsive Nanogel for Anticancer Drug Delivery. Oxidative Medicine and Cellular Longevity 2022; 2022:1-12. [PMID: 36193087 PMCID: PMC9526620 DOI: 10.1155/2022/1548410] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Accepted: 09/03/2022] [Indexed: 11/18/2022]
Abstract
In this study, to reduce the side effects of anticancer drugs and also to increase the efficiency of current drug delivery systems, a pH and temperature-responsive polymeric nanogel was synthesized by copolymerization of N-vinylcaprolactam (VCL) and acrylic acid (AA) monomers (P(VCL-co-AA)) with a novel cross-linker, triethylene glycol dimethacrylate (TEGDMA), as a biocompatible and nontoxic component. The structural and physicochemical features of the P(VCL-co-AA) nanogel were characterized by FT-IR, DLS/Zeta potential, FE-SEM, and 1HNMR techniques. The results indicated that spherical polymeric nanogel was successfully synthesized with a 182 nm diameter. The results showed that the polymerization process continues with the opening of the carbon-carbon double bond of monomers, which was approved by C-C band removing located at 1600 cm-1. Doxorubicin (Dox) as a chemotherapeutic agent was loaded into the P(VCL-co-AA), whit a significant loading of Dox (83%), and the drug release profile was investigated in the physiological and cancerous site simulated conditions. P(VCL-co-AA) exhibited a pH and temperature-responsive behavior, with an enhanced release rate in the cancerous site condition. The biocompatibility and nontoxicity of P(VCL-co-AA) were approved by MTT assay on the normal human foreskin fibroblasts-2 (HFF-2) cell line. Also, Dox-loaded P(VCL-co-AA) had excellent toxic behavior on the Michigan Cancer Foundation-7 (MCF-7) cell line as model cancerous cells. Moreover, Dox-loaded P(VCL-co-AA) had higher toxicity in comparison with free Dox, which would be a vast advantage in reducing Dox side effects in the clinical cancer treatment applications.
Collapse
|
3
|
Pinheiro WO, Costa do Santos MS, Farias GR, Fascineli ML, Ramos KLV, Duarte ECB, Damasceno EAM, da Silva JR, Joanitti GA, de Azevedo RB, Sousa MH, Lacava ZGM, Mosiniewicz-Szablewska E, Suchocki P, Morais PC, de Andrade LR. Combination of selol nanocapsules and magnetic hyperthermia hinders breast tumor growth in aged mice after a short-time treatment. Nanotechnology 2022; 33:205101. [PMID: 35100566 DOI: 10.1088/1361-6528/ac504c] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Accepted: 01/31/2022] [Indexed: 06/14/2023]
Abstract
Short time treatment with reduced dosages of selol-loaded PLGA nanocapsules (NcSel) combined with magnetic hyperthermia (MHT) is evaluated in aged Erhlich tumor-bearing mice. Clinical, hematological, biochemical, genotoxic and histopathological parameters are assessed during 7 d treatment with NcSel and MHT, separately or combined. The time evolution of the tumor volume is successfully modeled using the logistic mathematical model. The combined therapy comprising NcSel and MHT is able to hinder primary tumor growth and a case of complete tumor remission is recorded. Moreover, no metastasis was diagnosed and the adverse effects are negligible. NcSel plus MHT may represent an effective and safe alternative to cancer control in aged patients. Future clinical trials are encouraged.
Collapse
Affiliation(s)
- Willie Oliveira Pinheiro
- University of Brasilia, Post-Graduation Program in Sciences and Technologies in Health, Faculty of Ceilandia, 72220-275, Brasilia, DF, Brazil
- University of Brasilia, Faculty of Ceilandia, Green Nanotechnology Group, 72220-900 Brasilia, DF, Brazil
| | | | - Gabriel Ribeiro Farias
- University of Brasilia, Laboratory of Immunology and Inflammation, Department of Cell Biology, 70910-900 Brasilia, DF, Brazil
| | - Maria Luiza Fascineli
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
- Department of Morphology (DMORF), Health Science Center, Federal University of Paraíba, 58051-900, João Pessoa, Brazil
| | - Khellida Loiane Vieira Ramos
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | | | | | - Jaqueline Rodrigues da Silva
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | - Graziella Anselmo Joanitti
- University of Brasilia, Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, 72220-275 Brasilia-DF, Brazil
| | - Ricardo Bentes de Azevedo
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | - Marcelo Henrique Sousa
- University of Brasilia, Faculty of Ceilandia, Green Nanotechnology Group, 72220-900 Brasilia, DF, Brazil
| | - Zulmira Guerrero Marques Lacava
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | | | - Piotr Suchocki
- Department of Bioanalysis and Drug Analysis, Medical University of Warsaw, Warsaw, Poland
| | - Paulo Cesar Morais
- University of Brasília, Institute of Physics, Brasília DF 70910-900, Brazil
- Catholic University of Brasília, Genomic Sciences and Biotechnology, Brasília DF 70790-160, Brazil
| | - Laise Rodrigues de Andrade
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| |
Collapse
|
4
|
Szafraniec-Szczęsny J, Janik-Hazuka M, Odrobińska J, Zapotoczny S. Polymer Capsules with Hydrophobic Liquid Cores as Functional Nanocarriers. Polymers (Basel) 2020; 12:E1999. [PMID: 32887444 PMCID: PMC7565928 DOI: 10.3390/polym12091999] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 08/28/2020] [Accepted: 09/01/2020] [Indexed: 12/12/2022] Open
Abstract
Recent developments in the fabrication of core-shell polymer nanocapsules, as well as their current and future applications, are reported here. Special attention is paid to the newly introduced surfactant-free fabrication method of aqueous dispersions of nanocapsules with hydrophobic liquid cores stabilized by amphiphilic copolymers. Various approaches to the efficient stabilization of such vehicles, tailoring their cores and shells for the fabrication of multifunctional, navigable nanocarriers and/or nanoreactors useful in various fields, are discussed. The emphasis is placed on biomedical applications of polymer nanocapsules, including the delivery of poorly soluble active compounds and contrast agents, as well as their use as theranostic platforms. Other methods of fabrication of polymer-based nanocapsules are briefly presented and compared in the context of their biomedical applications.
Collapse
Affiliation(s)
- Joanna Szafraniec-Szczęsny
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
| | - Małgorzata Janik-Hazuka
- Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland; (M.J.-H.); (J.O.)
| | - Joanna Odrobińska
- Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland; (M.J.-H.); (J.O.)
| | - Szczepan Zapotoczny
- Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland; (M.J.-H.); (J.O.)
| |
Collapse
|
5
|
Pulagam KR, Gona KB, Gómez-Vallejo V, Meijer J, Zilberfain C, Estrela-Lopis I, Baz Z, Cossío U, Llop J. Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In vivo Evaluation. Molecules 2019; 24:E3609. [PMID: 31591329 PMCID: PMC6804187 DOI: 10.3390/molecules24193609] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Accepted: 10/01/2019] [Indexed: 02/07/2023] Open
Abstract
Background: Boron Neutron Capture Therapy (BNCT) is a binary approach to cancer therapy that requires accumulation of boron atoms preferentially in tumour cells. This can be achieved by using nanoparticles as boron carriers and taking advantage of the enhanced permeability and retention (EPR) effect. Here, we present the preparation and characterization of size and shape-tuned gold NPs (AuNPs) stabilised with polyethylene glycol (PEG) and functionalized with the boron-rich anion cobalt bis(dicarbollide), commonly known as COSAN. The resulting NPs were radiolabelled with 124I both at the core and the shell, and were evaluated in vivo in a mouse model of human fibrosarcoma (HT1080 cells) using positron emission tomography (PET). Methods: The thiolated COSAN derivatives for subsequent attachment to the gold surface were synthesized by reaction of COSAN with tetrahydropyran (THP) followed by ring opening using potassium thioacetate (KSAc). Iodination on one of the boron atoms of the cluster was also carried out to enable subsequent radiolabelling of the boron cage. AuNPs grafted with mPEG-SH (5 Kda) and thiolated COSAN were prepared by ligand displacement. Radiolabelling was carried out both at the shell (isotopic exchange) and at the core (anionic absorption) of the NPs using 124I to enable PET imaging. Results: Stable gold nanoparticles simultaneously functionalised with PEG and COSAN (PEG-AuNPs@[4]-) with hydrodynamic diameter of 37.8 ± 0.5 nm, core diameter of 19.2 ± 1.4 nm and ξ-potential of -18.0 ± 0.7 mV were obtained. The presence of the COSAN on the surface of the NPs was confirmed by Raman Spectroscopy and UV-Vis spectrophotometry. PEG-AuNPs@[4]- could be efficiently labelled with 124I both at the core and the shell. Biodistribution studies in a xenograft mouse model of human fibrosarcoma showed major accumulation in liver, lungs and spleen, and poor accumulation in the tumour. The dual labelling approach confirmed the in vivo stability of the PEG-AuNPs@[4]-. Conclusions: PEG stabilized, COSAN-functionalised AuNPs could be synthesized, radiolabelled and evaluated in vivo using PET. The low tumour accumulation in the animal model assayed points to the need of tuning the size and geometry of the gold core for future studies.
Collapse
Affiliation(s)
- Krishna R Pulagam
- Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, 20014 San Sebastian, Spain.
| | - Kiran B Gona
- Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, 20014 San Sebastian, Spain.
- Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511, USA.
- Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA.
| | | | - Jan Meijer
- Institute of Medical Physics and Biophysics, Leipzig University, Härtelstrasse 16-18, 04107 Leipzig, Germany.
| | - Carolin Zilberfain
- Felix Bloch Institute for Solid State Physics, Leipzig University, Linnéstraße 5, 04103 Leipzig, Germany.
| | - Irina Estrela-Lopis
- Felix Bloch Institute for Solid State Physics, Leipzig University, Linnéstraße 5, 04103 Leipzig, Germany.
| | - Zuriñe Baz
- Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, 20014 San Sebastian, Spain.
| | - Unai Cossío
- Radioimaging and Image Analysis Platform, CIC biomaGUNE, 20014 San Sebastian, Spain.
| | - Jordi Llop
- Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, 20014 San Sebastian, Spain.
- Centro de Investigación Biomédica en red Enfermedades Respiratorias-CIBERES, 28029 Madrid, Spain.
| |
Collapse
|
6
|
Ganassin R, Horst FH, Camargo NS, Chaves SB, Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Figueiró Longo JP, Azevedo RB, Muehlmann LA. Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46:1046-1052. [DOI: 10.1080/21691401.2018.1478423] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Affiliation(s)
- Rayane Ganassin
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
- Faculty of Ceilandia, University of Brasilia, Brasilia, Brazil
| | - Frederico Hillesheim Horst
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Nichollas Serafim Camargo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
- Faculty of Ceilandia, University of Brasilia, Brasilia, Brazil
| | - Sacha Braun Chaves
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Paulo César Morais
- Institute of Physics, University of Brasilia, Brasilia, Brazil
- School of Chemistry and Chemical Engineering, Anhui University, Hefei, PR China
| | | | - Piotr Suchocki
- Department of Bioanalysis and Drugs Analysis, Medical University of Warsaw, Warsaw, Poland
| | - João Paulo Figueiró Longo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Ricardo Bentes Azevedo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Luis Alexandre Muehlmann
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
- Faculty of Ceilandia, University of Brasilia, Brasilia, Brazil
| |
Collapse
|
7
|
Radicchi MA, de Oliveira JV, Mendes ACP, de Oliveira DM, Muehlmann LA, Morais PC, Azevedo RB, Longo JPF. Lipid nanoemulsion passive tumor accumulation dependence on tumor stage and anatomical location: a new mathematical model for in vivo imaging biodistribution studies. J Mater Chem B 2018; 6:7306-7316. [DOI: 10.1039/c8tb01577e] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nanoparticle delivery to tumor tissue is one of the most important applications of nanomedicine.
Collapse
Affiliation(s)
- Marina Arantes Radicchi
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - Jaqueline Vaz de Oliveira
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - Ana Clara Pova Mendes
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - Daniela Mara de Oliveira
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | | | - Paulo Cesar Morais
- Institute of Physics
- University of Brasilia
- Brasília DF 70910-900
- Brazil
- School of Chemistry and Chemical Engineering
| | - Ricardo Bentes Azevedo
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - João Paulo Figueiró Longo
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| |
Collapse
|